Home › Funds › Drexel Morgan & Co. › JNJ

Drexel Morgan & Co. position in JNJ

JOHNSON & JOHNSON · Health Care

Drexel Morgan & Co. reported holding 216,207 shares of JNJ (JOHNSON & JOHNSON) in its Q3 2026 13F filing — a position valued at US$57.2M, representing 7.66% of its reported portfolio and ranking #3 among its reported holdings. Drexel Morgan & Co. has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)216.21K sh
Reported value held$57.24M
Portfolio Weight7.66%
First reportedQ3 2023
Last changeHold
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Drexel Morgan & Co.'s JNJ position evolved

Drexel Morgan & Co. first disclosed a stake in JNJ in Q3 2023 at 215,997 shares (US$33.6M). The position peaked in Q3 2026 at 216,207 shares, worth US$57.2M. Across 13 filings, Drexel Morgan & Co. held the position steady without any share-count change. The most recent filing (Q3 2026) shows 216,207 shares valued at US$57.2M.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 216.00K $33.64M New
Q4 2023 216.10K $33.87M Hold
Q1 2024 216.26K $34.21M Hold
Q2 2024 216.26K $31.61M Hold
Q3 2024 216.26K $35.05M Hold
Q4 2024 216.26K $31.28M Hold
Q1 2025 216.26K $35.86M Hold
Q2 2025 216.26K $33.03M Hold
Q3 2025 216.21K $40.09M Hold
Q4 2025 216.21K $44.74M Hold
Q1 2026 216.21K $52.85M Hold
Q2 2026 216.21K $54.91M Hold
Q3 2026 216.21K $57.24M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 32 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$55.52B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$41.76B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has Drexel Morgan & Co. held JNJ?

Drexel Morgan & Co. has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Drexel Morgan & Co.'s current position in JNJ?

As of Q3 2026, Drexel Morgan & Co. holds 216.21K shares of JNJ (JOHNSON & JOHNSON), valued at $57.24M, representing 7.66% of its reported portfolio and ranking #3.

Has Drexel Morgan & Co. been buying or selling JNJ?

In the latest 13F filing (Q3 2026), Drexel Morgan & Co. held unchanged its position in JNJ. The position peaked in Q3 2026 at 216.21K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.